OPW
MRNA icon

Oxler Private Wealth’s Moderna MRNA Stock Holding History

Oxler Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-695
Closed -$82.2K – 257
2022
Q3 		$82.2K Hold
695
– – 0.05% 156
2022
Q2 		$99.3K Buy
+695
New +$99.3K 0.05% 129
2021
Q4 		– Sell
-695
Closed -$267K – 124
2021
Q3 		$267K Buy
+695
New +$256K 0.12% 114
2021
Q1 		– Sell
-695
Closed -$55K – 177
2020
Q4 		$55K Buy
+695
New +$70.3K 0.03% 153

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxler Private Wealth's MRNA Position: Q4 2022 in Review

Oxler Private Wealth sold out of Moderna (MRNA) in Q4 2022, closing a stake of 695 shares — an estimated $82.2K sold.

Oxler Private Wealth first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $267K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Oxler Private Wealth reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Oxler Private Wealth sold 695 Moderna shares in Q4 2022, an estimated $82.2K.
  • Oxler Private Wealth first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Oxler Private Wealth's Moderna position peaked at $267K in Q3 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Oxler Private Wealth's 13F filing for Q4 2022, filed 13 Feb 2023.